IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)
... Some sedative including Talen (bromazepam) can cause physiological and psychological dependence when taken regularly over a period of time, even at therapeutic doses (Ebert et al., 2006). Dependent users may get withdrawal symptoms ranging from restlessness and insomnia to convulsion and death. When ...
... Some sedative including Talen (bromazepam) can cause physiological and psychological dependence when taken regularly over a period of time, even at therapeutic doses (Ebert et al., 2006). Dependent users may get withdrawal symptoms ranging from restlessness and insomnia to convulsion and death. When ...
Drug treatment of hypertensive emergencies
... Updates are added as important new information is published. The literature review for version 14.2 is current through April 2006; this topic was last changed on May 8, 2006. The next version of UpToDate (14.3) will be released in October 2006. INTRODUCTION — Most patients with relatively severe hyp ...
... Updates are added as important new information is published. The literature review for version 14.2 is current through April 2006; this topic was last changed on May 8, 2006. The next version of UpToDate (14.3) will be released in October 2006. INTRODUCTION — Most patients with relatively severe hyp ...
Midterm review - February 26, 2004
... Autonomic Pharmacology: (Rosow) [huge chapter!] As long as you remember the sympathetic/parasympathetic system, the autonomic drugs are quite straightforward. When a drug is nonselective, its side effects are the other autonomic effects not mentioned in the therapeutic use. The following list only m ...
... Autonomic Pharmacology: (Rosow) [huge chapter!] As long as you remember the sympathetic/parasympathetic system, the autonomic drugs are quite straightforward. When a drug is nonselective, its side effects are the other autonomic effects not mentioned in the therapeutic use. The following list only m ...
Autonomic - EmergencyPedia
... a. strychnine stimulates glycine receptors – antagonizes glycine receptors b. atropine antagonises GABA receptors – antagonize muscarinic receptors c. butyrophenones stimulate dopamine receptors – antagonize DA receptors d. ondansotron antagonises seretonin receptors ...
... a. strychnine stimulates glycine receptors – antagonizes glycine receptors b. atropine antagonises GABA receptors – antagonize muscarinic receptors c. butyrophenones stimulate dopamine receptors – antagonize DA receptors d. ondansotron antagonises seretonin receptors ...
N receptors
... • At the NMJ, N receptors Pentameric with four types of subunits, two a subunits bind ACh for ligand gating • All other nAChRs, including those at the peripheral ganglia, have 2 a’s and 3 b’s ...
... • At the NMJ, N receptors Pentameric with four types of subunits, two a subunits bind ACh for ligand gating • All other nAChRs, including those at the peripheral ganglia, have 2 a’s and 3 b’s ...
anxiolytics2011-09
... Lower risk of development of tolerance and dependence than benzodiazepines . ...
... Lower risk of development of tolerance and dependence than benzodiazepines . ...
INHALED NITRIC OXIDE
... XV. ICD therapy present: a. Can now be implanted without thoracotomy b. Current generation devices terminate arrhythmias by anticardiac pacing, cardioversion, and defibrillation c. Considered by some experts to be the therapy of first choice in patients with ventricular tachycardias based on a numbe ...
... XV. ICD therapy present: a. Can now be implanted without thoracotomy b. Current generation devices terminate arrhythmias by anticardiac pacing, cardioversion, and defibrillation c. Considered by some experts to be the therapy of first choice in patients with ventricular tachycardias based on a numbe ...
lec#9 done by Dareen Mashaqbeh
... the case of an eight years old girl and menstruating or an eight years old male child with over-sexuality and in certain cases of hyperthyroidism . The over-activity of a receptor leads to diseases and this is know as constitutive receptor activity . *addition : when you have two drugs both of them ...
... the case of an eight years old girl and menstruating or an eight years old male child with over-sexuality and in certain cases of hyperthyroidism . The over-activity of a receptor leads to diseases and this is know as constitutive receptor activity . *addition : when you have two drugs both of them ...
Control Mechanisms of the GI Tract
... Block acetylcholine peripherally, which decreases intestinal motility and secretions May decrease gastric emptying (which may increase the tendency to vomit) Side effects include dry mouth, constipation, urinary retention, and tachycardia Examples: Aminopentamide Atropine Propantheline ...
... Block acetylcholine peripherally, which decreases intestinal motility and secretions May decrease gastric emptying (which may increase the tendency to vomit) Side effects include dry mouth, constipation, urinary retention, and tachycardia Examples: Aminopentamide Atropine Propantheline ...
Beta-Adrenergic Receptors, from Their Discovery and
... the 1-AR appears to be proapoptotic whereas stimulation of the 2-AR is not [31], an observation that has been extended to transgenic mouse models. Milano et al. [32] demonstrated previously that cardiac-directed overexpression of the human 2-AR in a transgenic mouse produced a significant increas ...
... the 1-AR appears to be proapoptotic whereas stimulation of the 2-AR is not [31], an observation that has been extended to transgenic mouse models. Milano et al. [32] demonstrated previously that cardiac-directed overexpression of the human 2-AR in a transgenic mouse produced a significant increas ...
HST-151
... Fluid retention: check weights, adjust sliding scale diuretics Bradycardia/heart block: occurs in 5-10% during dose titration; decrease dose by 50% if HR < 50, asymptomatic 2nd or 3rd degree heart block, monitor drug interactions Aldosterone antagonists Mechanism Inhibition of aldosterone, an ...
... Fluid retention: check weights, adjust sliding scale diuretics Bradycardia/heart block: occurs in 5-10% during dose titration; decrease dose by 50% if HR < 50, asymptomatic 2nd or 3rd degree heart block, monitor drug interactions Aldosterone antagonists Mechanism Inhibition of aldosterone, an ...
Brief Receptor Theory
... – the relative maximal response caused by a drug in a tissue preparation. A full agonist causes a maximal effect equal to that of the endogenous ligand (or sometimes another reference compound if the endogenous ligand is not known); a partial agonist causes less than a maximal response. – Intrinsic ...
... – the relative maximal response caused by a drug in a tissue preparation. A full agonist causes a maximal effect equal to that of the endogenous ligand (or sometimes another reference compound if the endogenous ligand is not known); a partial agonist causes less than a maximal response. – Intrinsic ...
*****************#***********#******|6******7#**8#**9
... • At the NMJ, N receptors Pentameric with four types of subunits, two a subunits bind ACh for ligand gating • All other nAChRs, including those at the peripheral ganglia, have 2 a’s and 3 b’s ...
... • At the NMJ, N receptors Pentameric with four types of subunits, two a subunits bind ACh for ligand gating • All other nAChRs, including those at the peripheral ganglia, have 2 a’s and 3 b’s ...
SEDATIVE/HYPNOTICS (Antianxiety Drugs)
... has active metabolites (desmethyldiazepam and oxazepam) and is long acting (t½ = 20-80 hr). Differing times of onset and elimination half-lives (long half-life => daytime sedation). ...
... has active metabolites (desmethyldiazepam and oxazepam) and is long acting (t½ = 20-80 hr). Differing times of onset and elimination half-lives (long half-life => daytime sedation). ...
Uptravi
... • No difference in mortality between groups • Addition of selexipag to baseline regimen of two meds gave benefits consistent with overall treatment effect • Similar efficacy regardless of dose range Sitbon O, et al. N Engl J Med. 2015;373(26):2522-33. ...
... • No difference in mortality between groups • Addition of selexipag to baseline regimen of two meds gave benefits consistent with overall treatment effect • Similar efficacy regardless of dose range Sitbon O, et al. N Engl J Med. 2015;373(26):2522-33. ...
nicotinic receptors
... Skin inhibition of sweating, hyperthermia and flushing of the skin of the face as a reflux to the inhibition of sweating. Remember there is no direct innervation by parasympathetic nervous system on blood vessels but there are some exceptions: 1- the skin of the face: activation of parasympathetic ...
... Skin inhibition of sweating, hyperthermia and flushing of the skin of the face as a reflux to the inhibition of sweating. Remember there is no direct innervation by parasympathetic nervous system on blood vessels but there are some exceptions: 1- the skin of the face: activation of parasympathetic ...
5-HT2a – receptor agonist
... • Routes of exposure: ingestion (only with MAOI – othervise is metabolised in GIT), inhalation ...
... • Routes of exposure: ingestion (only with MAOI – othervise is metabolised in GIT), inhalation ...
Lecture 05 - binding quant - Cal State LA
... (theoretically, KD = EC50), it does not account for agonists that do not produce the maximum effect. Modified occupancy theory: modified to separate the binding affinity from the intrinsic activity () of the compound. That is, a compound can bind tightly, but cause a little or no effect. ...
... (theoretically, KD = EC50), it does not account for agonists that do not produce the maximum effect. Modified occupancy theory: modified to separate the binding affinity from the intrinsic activity () of the compound. That is, a compound can bind tightly, but cause a little or no effect. ...
Drugs of Abuse - EMS Update 2017
... • Mid-2000s Pfizer patented the base structure for INACA-class compounds • Were being studied as analgesics • None have made it to phase I trials Structure depicted in the Pfizer patent ...
... • Mid-2000s Pfizer patented the base structure for INACA-class compounds • Were being studied as analgesics • None have made it to phase I trials Structure depicted in the Pfizer patent ...
Clinical Implications of Chirality and Stereochemistry in
... exists as a racemic mixture of Rand S- enantiomers. Studies have shown that the S-thalidomide ...
... exists as a racemic mixture of Rand S- enantiomers. Studies have shown that the S-thalidomide ...
Cimetidine - Clemson University
... • This results in reduction of gastric volume and acidity. It also decreases the amount of gastric acid released in response to other stimuli. ...
... • This results in reduction of gastric volume and acidity. It also decreases the amount of gastric acid released in response to other stimuli. ...
Pharmacology introduction Lecture three Dr. nahlah 21-10
... e.g. nicotinic andGABAA receptors. The response takes milliseconds. Acetylcholine binds to nicotinic receptors Na+ influx ...
... e.g. nicotinic andGABAA receptors. The response takes milliseconds. Acetylcholine binds to nicotinic receptors Na+ influx ...
drugs affecting the autonomic nervous system
... 2. the sympathetic fibers to the sweat gland and blood vessels of skeletal muscles are cholinergic. 3. all preganglionic synapses of the ans are cholinergic 4. these are also found in the pns and contols the voluntary skeletal muscle action. 5. they are also found in the cns. ...
... 2. the sympathetic fibers to the sweat gland and blood vessels of skeletal muscles are cholinergic. 3. all preganglionic synapses of the ans are cholinergic 4. these are also found in the pns and contols the voluntary skeletal muscle action. 5. they are also found in the cns. ...
Drug Chart Part 1 - Website of Neelay Gandhi
... -Zollinger-ellison syndrome (relapse of ulcer after shortterm tx or abrupt cessation) -GERD -Peptic ulcers-hiatal hernia -Tylenol O.D. (Cimetidine) ...
... -Zollinger-ellison syndrome (relapse of ulcer after shortterm tx or abrupt cessation) -GERD -Peptic ulcers-hiatal hernia -Tylenol O.D. (Cimetidine) ...